Sector News

Report: Private equity firms eyeing Bayer MaterialScience

October 23, 2014
Chemical Value Chain
Private equity firms are mulling possible offers for Bayer MaterialScience (BMS), the German life science company’s major polyurethanes and polycarbonates business, according to a report on Reuters, citing sources familiar with the situation. Analysts have already speculated that BMS, which could be worth around €10 billion ($12.7 billion) on a debt-free basis when it is separated from Bayer next year, might also attract an industry buyer keen to establish a leadership position in BMS’s value-added plastics markets. 
 
> Read the full article on the Chemical Week website
 
By Natasha Alperowicz
 

comments closed

Related News

January 29, 2023

Dow and 3M cut thousands of jobs

Chemical Value Chain

3M and Dow have announced they are cutting thousands of roles from their global workforces in response to economic pressures. Dow has said it will cut 2,000 jobs across its global workforce (around 5%) in a bid to save US$1bn in 2023. The company says it will also cut costs by shutting down “select assets”, though it did not note where it would halt operations.

January 29, 2023

Sweden discovers Europe’s largest rare earths deposit

Chemical Value Chain

Sweden’s state mining firm has discovered what could be Europe’s largest rare earths deposit, and says it could help the bloc reduce its reliance on imports of minerals needed to manufacture clean technologies and meet climate targets.

January 29, 2023

Avantium to supply Henkel with plant-based FDCA

Chemical Value Chain

Henkel and Avantium have been partners since 2019, when Henkel joined the PEFerence consortium. This consortium of partners, coordinated by Avantium, aims to establish an innovative supply chain for FDCA and PEF (polyethylene furanoate).

How can we help you?

We're easy to reach